Dr. Tolikas most recently served as CEO at Wyss Center for Bio & Neuroengineering in Switzerland, Before that, she spent nearly 10 years as an operations director at Cambridge, Mass.-based Harvard University, where she was an important part of the Wyss Center’s growth at the university, according to a March 15 news release.
At Dana-Farber, Dr. Tolikas will be tasked with leading the organization’s innovation strategy by forming strategic partnerships and identifying opportunities for technology improvement.
“Mary’s extensive experience in establishing and growing technology-based organizations in both industry and academia will serve her well in this role and will be instrumental as she grows our work in this important area,” Dana-Farber CEO Laurie Glimcher, MD, said in the release.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
